Skip to main content
. 2022 Jun 22;109:102429. doi: 10.1016/j.ctrv.2022.102429

Table 4.

Neoantigen prediction softwares.

Software (references) Principle Year
NeoPredPipe [140] Connects commonly used bioinformatics software using custom python scripts giving neoantigen burden, immune stimulation potential, tumor heterogeneity and HLA haplotype of patients. 2019
Strelka2 [141] Estimates error or deletion parameters of each sample improved tumor liquid analysis 2018
MuPeXI [142] Identifies tumor-specific peptides through the extraction and induction of mutant peptides, it can predict immunogenicity and evaluate the potential of novel peptides 2017
CloudNeo pipeline [143] The docker container executes the tasks. After giving as an input mutant VCF file and bam FILE representing HLA typing, the software predicts HLA affinity all mutant peptides. 2017
pVAC-Seq [144] Integrates tumor mutation and expression data to identify personalized mutagens through personalized sequencing. 2016
NetMHCpan [145] The sequences are compared using artificial intelligence neural network and predict affinity of molecular peptide-MHC-I type 2016
VariantEffect Predictor Tool [146] It uses automated annotations to manual review time and prioritize variants 2016
Somaticseq [147] It uses a randomized enhancement algorithm, which has more than 70 individual genome sequence features based on candidate sites to accurately detect somatic mutations 2015
OptiType [148] It uses an HLA type algorithm with a linear programming that gives sequencing databases comprising RNA, exome and whole genome sequencings. 2014
ATHLATES [149] It assembles allele recognition, pair interface applied to short sequences and HLA genotyping at allele level achieved via exon sequencing 2013
VarScan2 [150] It detects somatic and copy number mutations within tumor-normal exome data using a heuristic statistical algorithm. 2012
HLAminer [151] Through a shotgun sequencing Illumina database platform, predicts HLA type through an orientation of the assembly of the shotgun sequence data to then compare it with databases of allele sequences used as references. 2012
Strelka [152] It uses a Bayesian model that matches normal-tumor sample sequencing data to analyze and predict with high accuracy and sensitivity somatic cellular variations 2012
SMMPMBEC [153] Through a Beyesian matrix based on optimal neural network they can predict peptide molecules with MHC-I 2009
UCSC browser [154] The fusion of various databases can give fast and accurate access to any gene sequence. 2002